Drugs Controller-general-of-india

Showing of 1 - 20 from 7 results
Drugs Controller-general-of-india - Total results - 7
DCGI approves commercial launch of Tata Group's low-cost COVID-19 test 'Feluda'
India

DCGI approves commercial launch of Tata Group's low-cost COVID-19 test 'Feluda'

This test uses an indigenously-developed, cutting-edge CRISPR technology for detecting the virus' genome sequence

Serum Institute of India gets DCGI's nod to resume clinical trial of Oxford COVID-19 vaccine
India

Serum Institute of India gets DCGI's nod to resume clinical trial of Oxford COVID-19 vaccine

SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events

India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine
science

India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine

Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine

DCGI approves psoriasis injection for 'restricted emergency use' to treat COVID-19 patients
India

DCGI approves psoriasis injection for 'restricted emergency use' to treat COVID-19 patients

Drugs Controller General of India approved monoclonal antibody injection Itolizumab for limited use to treat moderate to severe cases of COVID-19.

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients
India

COVID-19 treatment: Fabiflu by Glenmark, HCQ, Remdesivir and other drugs that are being used to treat coronavirus patients

Favipiravir is an antiviral drug which was developed by a Japanese pharma company, Fujifilm Toyama Chemical, to treat influenza.

Biocon gets DCGI nod for emergency use of CytoSorb to treat critical COVID-19 patients
Business

Biocon gets DCGI nod for emergency use of CytoSorb to treat critical COVID-19 patients

Biotechnology major Biocon on Wednesday said its subsidiary has received approval from the Drugs Controller General of India (DCGI) for a medical device to treat critical COVID-19 patients

Probe ordered after eradicated type 2 polio virus found in oral vaccine; Ghaziabad pharma company MD held
India

Probe ordered after eradicated type 2 polio virus found in oral vaccine; Ghaziabad pharma company MD held

The Health Ministry has ordered a probe after traces of polio type 2 virus were found in some batches of oral polio vaccine (OPV) manufactured by a Ghaziabad-based pharmaceutical company, even as the firm's managing director was arrested Saturday